help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, R. A.
Right arrow Articles by Roodman, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, R. A.
Right arrow Articles by Roodman, G. D.

Endocrinology, Vol 124, 1424-1427, Copyright © 1989 by Endocrine Society


ARTICLES

Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice

RA Johnson, BF Boyce, GR Mundy and GD Roodman
Audie L. Murphy Veterans Administration Hospital, San Antonio, Texas 78284.

We used a Chinese hamster ovary cell line that had been transfected with the human tumor necrosis factor (TNF) gene and constitutively produced TNF when transplanted in nude mice to study the effects of continuous production of TNF on calcium homeostasis. Continuous exposure to TNF caused increased osteoclastic bone resorption and humoral hypercalcemia in these animals. The mice bearing TNF-producing tumors were significantly hypercalcuric compared to mice bearing control tumors, but urinary cAMP excretion was unchanged. Mice bearing Chinese hamster ovary cell tumors containing the empty vector did not demonstrate hypercalcemia or increased bone resorption. This model system using transfected cells to continuously produce cytokines in vivo is more analogous to the pathophysiological conditions present in patients than intermittent injections and can produce much longer exposures than infusion pumps. Such model systems should allow a better understanding of the role of factors involved in humoral hypercalcemia.


This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
G A Clines and T A Guise
Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone
Endocr. Relat. Cancer, September 1, 2005; 12(3): 549 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. P. Moffett, J. M. Zmuda, J. I. Oakley, T. J. Beck, J. A. Cauley, K. L. Stone, L.-Y. Lui, K. E. Ensrud, T. A. Hillier, M. C. Hochberg, et al.
Tumor Necrosis Factor-{alpha} Polymorphism, Bone Strength Phenotypes, and the Risk of Fracture in Older Women
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3491 - 3497.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. O. Oyajobi, G. Franchin, P. J. Williams, D. Pulkrabek, A. Gupta, S. Munoz, B. Grubbs, M. Zhao, D. Chen, B. Sherry, et al.
Dual effects of macrophage inflammatory protein-1{alpha} on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease
Blood, July 1, 2003; 102(1): 311 - 319.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Tzagarakis-Foster, R. Geleziunas, A. Lomri, J. An, and D. C. Leitman
Estradiol Represses Human T-cell Leukemia Virus Type 1 Tax Activation of Tumor Necrosis Factor-alpha Gene Transcription
J. Biol. Chem., November 15, 2002; 277(47): 44772 - 44777.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz
Changes in Proinflammatory Cytokine Activity after Menopause
Endocr. Rev., February 1, 2002; 23(1): 90 - 119.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
K. C. Anderson, J. D. Shaughnessy Jr., B. Barlogie, J.-L. Harousseau, and G. D. Roodman
Multiple Myeloma
Hematology, January 1, 2002; 2002(1): 214 - 240.
[Abstract] [Full Text]


Home page
JCOHome page
G. D. Roodman
Biology of Osteoclast Activation in Cancer
J. Clin. Oncol., August 1, 2001; 19(15): 3562 - 3571.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. E. Compston
Sex Steroids and Bone
Physiol Rev, January 1, 2001; 81(1): 419 - 447.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G.-Q. Yao, B.-h. Sun, K. L. Insogna, and E. C. Weir
Nuclear Factor-{kappa}B p50 Is Required for Tumor Necrosis Factor-{alpha}-Induced Colony-Stimulating Factor-1 Gene Expression in Osteoblasts
Endocrinology, August 1, 2000; 141(8): 2914 - 2922.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. E. Hak, H. A. P. Pols, A. M. van Hemert, A. Hofman, and J. C. M. Witteman
Progression of Aortic Calcification Is Associated With Metacarpal Bone Loss During Menopause : A Population-Based Longitudinal Study
Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1926 - 1931.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. An, R. C. J. Ribeiro, P. Webb, J.-A. Gustafsson, P. J. Kushner, J. D. Baxter, and D. C. Leitman
Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators
PNAS, December 21, 1999; 96(26): 15161 - 15166.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C.-Y. Chiang, G. Kyritsis, D. T. Graves, and S. Amar
Interleukin-1 and Tumor Necrosis Factor Activities Partially Account for Calvarial Bone Resorption Induced by Local Injection of Lipopolysaccharide
Infect. Immun., August 1, 1999; 67(8): 4231 - 4236.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Zubery, C. R. Dunstan, B. M. Story, L. Kesavalu, J. L. Ebersole, S. C. Holt, and B. F. Boyce
Bone Resorption Caused by Three Periodontal Pathogens In Vivo in Mice Is Mediated in Part by Prostaglandin
Infect. Immun., September 1, 1998; 66(9): 4158 - 4162.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. A. Guise and G. R. Mundy
Cancer and Bone
Endocr. Rev., February 1, 1998; 19(1): 18 - 54.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society